Mitochondrial diseases present a diagnostic challenge due to their clinical and genetic heterogeneity. Achieving comprehensive molecular diagnosis via a conventional candidate-gene approach is likely, therefore, to be labour- and cost-intensive given the expanding number of mitochondrial disease genes. The advent of whole exome sequencing (WES) and whole genome sequencing (WGS) hold the potential of higher diagnostic yields due to the universality and unbiased nature of the methods. However, these approaches are subject to the escalating challenge of variant interpretation. Thus, integration of functional ‘multi-omics’ data, such as transcriptomics, is emerging as a powerful complementary tool in the diagnosis of mitochondrial disease patients for whom extensive prior analysis of DNA sequencing has failed to return a genetic diagnosis.
Advancing genomic approaches to the molecular diagnosis of mitochondrial disease
- Views Icon Views
- Share Icon Share
- Cite Icon Cite
Caterina Garone, Michal Minczuk, Sarah Louise Stenton, Holger Prokisch; Advancing genomic approaches to the molecular diagnosis of mitochondrial disease. Essays Biochem 20 July 2018; 62 (3): 399–408. doi: https://doi.org/10.1042/EBC20170110
Download citation file: